1. Home
  2. MGTX vs JRVR Comparison

MGTX vs JRVR Comparison

Compare MGTX & JRVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGTX
  • JRVR
  • Stock Information
  • Founded
  • MGTX 2015
  • JRVR 2002
  • Country
  • MGTX United States
  • JRVR Bermuda
  • Employees
  • MGTX N/A
  • JRVR N/A
  • Industry
  • MGTX Biotechnology: Biological Products (No Diagnostic Substances)
  • JRVR Property-Casualty Insurers
  • Sector
  • MGTX Health Care
  • JRVR Finance
  • Exchange
  • MGTX Nasdaq
  • JRVR Nasdaq
  • Market Cap
  • MGTX 479.9M
  • JRVR 241.0M
  • IPO Year
  • MGTX N/A
  • JRVR 2005
  • Fundamental
  • Price
  • MGTX $5.77
  • JRVR $4.60
  • Analyst Decision
  • MGTX Strong Buy
  • JRVR Buy
  • Analyst Count
  • MGTX 2
  • JRVR 5
  • Target Price
  • MGTX $23.50
  • JRVR $10.40
  • AVG Volume (30 Days)
  • MGTX 314.5K
  • JRVR 383.6K
  • Earning Date
  • MGTX 11-13-2024
  • JRVR 02-26-2025
  • Dividend Yield
  • MGTX N/A
  • JRVR 3.48%
  • EPS Growth
  • MGTX N/A
  • JRVR N/A
  • EPS
  • MGTX N/A
  • JRVR N/A
  • Revenue
  • MGTX $13,929,000.00
  • JRVR $796,817,000.00
  • Revenue This Year
  • MGTX N/A
  • JRVR N/A
  • Revenue Next Year
  • MGTX $1,391.84
  • JRVR $7.46
  • P/E Ratio
  • MGTX N/A
  • JRVR N/A
  • Revenue Growth
  • MGTX 108.24
  • JRVR 19.38
  • 52 Week Low
  • MGTX $3.85
  • JRVR $4.35
  • 52 Week High
  • MGTX $7.37
  • JRVR $11.49
  • Technical
  • Relative Strength Index (RSI)
  • MGTX 40.89
  • JRVR 41.82
  • Support Level
  • MGTX $5.60
  • JRVR $4.54
  • Resistance Level
  • MGTX $6.29
  • JRVR $4.95
  • Average True Range (ATR)
  • MGTX 0.35
  • JRVR 0.16
  • MACD
  • MGTX -0.04
  • JRVR 0.01
  • Stochastic Oscillator
  • MGTX 16.04
  • JRVR 12.00

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

About JRVR James River Group Holdings Ltd.

James River Group Holdings Ltd owns and operates a group of specialty insurance and reinsurance companies. It reports business into three segments. The Excess and Surplus Lines segment, which is the key revenue driver, offers commercial excess and surplus lines liability and excess property insurance products; The Specialty Admitted Insurance segment focuses on niche classes within the standard insurance markets with a primary focus on fronting business, where it retains a minority share of the risk and seek to earn fee income by allowing other carriers and producers to use its licensure, ratings, expertise and infrastructure. and the Corporate and other segment consists of the management and treasury activities of holding companies, equity compensation for the group.

Share on Social Networks: